AVNS

NYSEStock

Avanos Medical, Inc.

$13.69+0.26 (+1.94%)

52-Week Range

$9.89
$15.46

Key Stats

Market Cap

636.6M

P/E Ratio

Dividend Yield

Beta

1.09

Volume

487.9K

Avg Volume

672.5K

Performance

1M

-9.01%

3M

+13.24%

6M

+9.45%

YTD

+20.13%

1Y

-7.12%

3Y

-51.81%

5Y

-72.06%

Price Chart

ETF Exposure

AVNS is held by 116 ETFs

ETFFund NameWeight
AORiShares Core 60/40 Balanced Allocation ETF0.00%
DFUSDimensional - US Equity Market ETF0.00%
ITDBiShares LifePath Target Date 2030 ETF0.00%
ITDCiShares LifePath Target Date 2035 ETF0.00%
ITDDiShares LifePath Target Date 2040 ETF0.00%
ITDEiShares LifePath Target Date 2045 ETF0.00%
ITDFiShares LifePath Target Date 2050 ETF0.00%
ITDGiShares LifePath Target Date 2055 ETF0.00%
ITDHiShares LifePath Target Date 2060 ETF0.00%
ITDIiShares LifePath Target Date 2065 ETF0.00%
ITDJiShares LifePath Target Date 2070 ETF0.00%
MMTMState Street SPDR S&P 1500 Momentum Tilt ETF0.00%
VCNS.TOVanguard Conservative ETF Portfolio0.00%
VEQT.TOVanguard All-Equity ETF Portfolio0.00%
VRIF.TOVanguard Retirement Income ETF Portfolio0.00%
XEQT.TOiShares Core Equity ETF Portfolio0.00%
PreviousPage 3 of 3

About AVNS ETF Exposure

Avanos Medical, Inc. (AVNS) is held by 116 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 636.6M, AVNS is a widely held institutional stock. The stock currently trades at $13.69. Investors can gain exposure to AVNS through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold AVNS, sorted by portfolio weight.